{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:14:59Z","timestamp":1790511299289,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG048099"],"award-info":[{"award-number":["AG048099"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG16573"],"award-info":[{"award-number":["AG16573"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["BFG-14-317000"],"award-info":[{"award-number":["BFG-14-317000"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ANR","award":["ADORATAU, CYTOKALZ, SPREADTAU"],"award-info":[{"award-number":["ADORATAU, CYTOKALZ, SPREADTAU"]}]},{"DOI":"10.13039\/501100003750","name":"Association France Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["RT3-07893"],"award-info":[{"award-number":["RT3-07893"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40478-016-0336-1","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T07:05:14Z","timestamp":1466751914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Increased tauopathy drives microglia-mediated clearance of beta-amyloid"],"prefix":"10.1186","volume":"4","author":[{"given":"Wesley","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edsel A.","family":"Abud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Nassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bu\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne W.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7770-7157","authenticated-orcid":false,"given":"Mathew","family":"Blurton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,23]]},"reference":[{"issue":"3","key":"336_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H et al. Inflammation and Alzheimer\u2019s disease. Neurobiol Aging. 2000;21(3):383\u2013421.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"336_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neurobiolaging.2009.06.005","volume":"32","author":"G Amadoro","year":"2011","unstructured":"Amadoro G et al. Endogenous A\u03b2 causes cell death via early tau hyperphosphorylation. Neurobiol Aging. 2011;32(6):969\u201390.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"336_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0006-8993(00)03176-0","volume":"894","author":"J Apelt","year":"2001","unstructured":"Apelt J, Schliebs R. \u03b2-Amyloid-induced glial expression of both pro-and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res. 2001;894(1):21\u201330.","journal-title":"Brain Res"},{"key":"336_CR4","doi-asserted-by":"crossref","unstructured":"Asai H. et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nature neuroscience. 2015;18(11):1584\u201393.","DOI":"10.1038\/nn.4132"},{"issue":"2","key":"336_CR5","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.jalz.2014.02.001","volume":"10","author":"Association A.s","year":"2014","unstructured":"Association A.s. 2014 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2014;10(2):e47\u201392.","journal-title":"Alzheimers Dement"},{"issue":"2\u20133","key":"336_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0165-5728(90)90108-Y","volume":"30","author":"BP Barna","year":"1990","unstructured":"Barna BP et al. Human astrocytes proliferate in response to tumor necrosis factor alpha. J Neuroimmunol. 1990;30(2\u20133):239\u201343.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"336_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.nbd.2011.04.022","volume":"43","author":"K Belarbi","year":"2011","unstructured":"Belarbi K et al. Beneficial effects of exercise in a transgenic mouse model of Alzheimer\u2019s disease-like Tau pathology. Neurobiol Dis. 2011;43(2):486\u201394.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"336_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, De Strooper B. The toxic A [beta] oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci. 2012;15(3):349\u201357.","journal-title":"Nat Neurosci"},{"issue":"6","key":"336_CR9","doi-asserted-by":"publisher","first-page":"1510.e19","DOI":"10.1016\/j.neurobiolaging.2013.12.010","volume":"35","author":"BA Benitez","year":"2014","unstructured":"Benitez BA et al. Missense variant in TREML2 protects against Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(6):1510.e19\u201326.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"336_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar K et al. Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010;68(1):19\u201331.","journal-title":"Neuron"},{"key":"336_CR11","doi-asserted-by":"crossref","unstructured":"Bisht K. et al. Dark microglia: A new phenotype predominantly associated with pathological states. Glia. 2016;64(5):826\u201339.","DOI":"10.1002\/glia.22966"},{"issue":"1","key":"336_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong J-S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57\u201369.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"336_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/156720506779025242","volume":"3","author":"M Blurton-Jones","year":"2006","unstructured":"Blurton-Jones M, Laferla FM. Pathways by which Abeta facilitates tau pathology. Curr Alzheimer Res. 2006;3(5):437\u201348.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"336_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-3940(01)02461-2","volume":"318","author":"A Boutajangout","year":"2002","unstructured":"Boutajangout A et al. Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1. Neurosci Lett. 2002;318(1):29\u201333.","journal-title":"Neurosci Lett"},{"issue":"7","key":"336_CR15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM et al. CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013;16(7):848\u201350.","journal-title":"Nat Neurosci"},{"issue":"2","key":"336_CR16","first-page":"212","volume":"66","author":"G Bramblett","year":"1992","unstructured":"Bramblett G, Trojanowski J, Lee V. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Laboratory investigation; a journal of technical methods and pathology. 1992;66(2):212\u201322.","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"issue":"48","key":"336_CR17","doi-asserted-by":"publisher","first-page":"17345","DOI":"10.1523\/JNEUROSCI.0172-12.2012","volume":"32","author":"MA Chabrier","year":"2012","unstructured":"Chabrier MA et al. Soluble abeta promotes wild-type tau pathology in vivo. J Neurosci. 2012;32(48):17345\u201350.","journal-title":"J Neurosci"},{"key":"336_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2014.01.007","volume":"64","author":"MA Chabrier","year":"2014","unstructured":"Chabrier MA et al. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer\u2019s disease. Neurobiol Dis. 2014;64:107\u201317.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"336_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","volume":"85","author":"P Chakrabarty","year":"2015","unstructured":"Chakrabarty P et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron. 2015;85(3):519\u201333.","journal-title":"Neuron"},{"issue":"4","key":"336_CR20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","volume":"21","author":"CK Combs","year":"2001","unstructured":"Combs CK et al. \u03b2-Amyloid stimulation of microglia and monocytes results in TNF\u03b1-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci. 2001;21(4):1179\u201388.","journal-title":"J Neurosci"},{"issue":"6","key":"336_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nn1472","volume":"8","author":"D Davalos","year":"2005","unstructured":"Davalos D et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 2005;8(6):752\u20138.","journal-title":"Nat Neurosci"},{"issue":"1","key":"336_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-8-2","volume":"8","author":"WA Eimer","year":"2013","unstructured":"Eimer WA, Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal A\u03b242 accumulation and Caspase-3 activation. Mol Neurodegener. 2013;8(1):1\u201312.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"336_CR23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-2007-11406","volume":"11","author":"M Fiala","year":"2007","unstructured":"Fiala M et al. Phagocytosis of amyloid-\u03b2 and inflammation: two faces of innate immunity in Alzheimer\u2019s disease. J Alzheimers Dis. 2007;11(4):457\u201363.","journal-title":"J Alzheimers Dis"},{"issue":"5534","key":"336_CR24","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J et al. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 2001;293(5534):1491\u20135.","journal-title":"Science"},{"issue":"4","key":"336_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A et al. Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78(4):631\u201343.","journal-title":"Neuron"},{"key":"336_CR26","unstructured":"Griffin W. IL-1 and the cytokine cycle in Alzheimer\u2019s disease. in Journal of Neurochemistry. 2000. Lippincott Williams & Wilkins 530 Walnut ST, Philadelphia. PA 19106\u20133621 USA."},{"issue":"1","key":"336_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","volume":"8","author":"W Griffin","year":"1998","unstructured":"Griffin W et al. Glial\u2010neuronal interactions in Alzheimer\u2019s disease: The potential role of a \u2018cytokine cycle\u2019in disease progression. Brain Pathol. 1998;8(1):65\u201372.","journal-title":"Brain Pathol"},{"issue":"2","key":"336_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"3","key":"336_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","volume":"85","author":"M-V Guillot-Sestier","year":"2015","unstructured":"Guillot-Sestier M-V et al. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron. 2015;85(3):534\u201348.","journal-title":"Neuron"},{"issue":"5580","key":"336_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136.","journal-title":"Science"},{"issue":"5054","key":"336_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184.","journal-title":"Science"},{"issue":"10","key":"336_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41(10):1088\u201393.","journal-title":"Nat Genet"},{"issue":"2","key":"336_CR33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0006-8993(97)01215-8","volume":"780","author":"B Hauss-Wegrzyniak","year":"1998","unstructured":"Hauss-Wegrzyniak B et al. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer\u2019s disease. Brain Res. 1998;780(2):294\u2013303.","journal-title":"Brain Res"},{"issue":"8","key":"336_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","volume":"117","author":"MT Heneka","year":"2010","unstructured":"Heneka MT et al. Neuroinflammatory processes in Alzheimer\u2019s disease. J Neural Transm. 2010;117(8):919\u201347.","journal-title":"J Neural Transm"},{"key":"336_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.nbd.2013.09.010","volume":"62","author":"C H\u00e9raud","year":"2014","unstructured":"H\u00e9raud C et al. Increased misfolding and truncation of tau in APP\/PS1\/tau transgenic mice compared to mutant tau mice. Neurobiol Dis. 2014;62:100\u201312.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"336_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0006-8993(97)01318-8","volume":"785","author":"J Hu","year":"1998","unstructured":"Hu J et al. Amyloid-\u03b2 peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 1998;785(2):195\u2013206.","journal-title":"Brain Res"},{"issue":"2","key":"336_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/glia.10150","volume":"40","author":"K Inoue","year":"2002","unstructured":"Inoue K. Microglial activation by purines and pyrimidines. Glia. 2002;40(2):156\u201363.","journal-title":"Glia"},{"issue":"2","key":"336_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha GA et al. Alz\u201050 and MC\u20101, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res. 1997;48(2):128\u201332.","journal-title":"J Neurosci Res"},{"issue":"39","key":"336_CR39","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","volume":"25","author":"M Kitazawa","year":"2005","unstructured":"Kitazawa M et al. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer\u2019s disease. J Neurosci. 2005;25(39):8843\u201353.","journal-title":"J Neurosci"},{"issue":"36","key":"336_CR40","doi-asserted-by":"publisher","first-page":"8240","DOI":"10.1523\/JNEUROSCI.1808-05.2005","volume":"25","author":"J Koenigsknecht-Talboo","year":"2005","unstructured":"Koenigsknecht-Talboo J, Landreth GE. Microglial phagocytosis induced by fibrillar \u03b2-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci. 2005;25(36):8240\u20139.","journal-title":"J Neurosci"},{"issue":"1","key":"336_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jneuroim.2005.01.015","volume":"162","author":"R Kuno","year":"2005","unstructured":"Kuno R et al. Autocrine activation of microglia by tumor necrosis factor-\u03b1. J Neuroimmunol. 2005;162(1):89\u201396.","journal-title":"J Neuroimmunol"},{"issue":"12","key":"336_CR42","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"J-C Lambert","year":"2013","unstructured":"Lambert J-C et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"336_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-9-33","volume":"9","author":"V Landel","year":"2014","unstructured":"Landel V et al. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer\u2019s disease. Mol Neurodegener. 2014;9(1):1\u201318.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"336_CR44","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.neurobiolaging.2014.03.027","volume":"35","author":"C Laurent","year":"2014","unstructured":"Laurent C et al. Beneficial effects of caffeine in a transgenic model of Alzheimer\u2019s disease-like tau pathology. Neurobiol Aging. 2014;35(9):2079\u201390.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"336_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/glia.440120407","volume":"12","author":"SC Lee","year":"1994","unstructured":"Lee SC et al. GM\u2010CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia. 1994;12(4):309\u201318.","journal-title":"Glia"},{"issue":"2","key":"336_CR46","first-page":"81","volume":"42","author":"E Lewandowska","year":"2003","unstructured":"Lewandowska E et al. Ultrastructural evaluation of activated forms of microglia in human brain in selected neurological diseases (SSPE, Wilson\u2019s disease and Alzheimer\u2019s disease). Folia Neuropathol. 2003;42(2):81\u201391.","journal-title":"Folia Neuropathol"},{"issue":"5534","key":"336_CR47","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001;293(5534):1487\u201391.","journal-title":"Science"},{"issue":"1","key":"336_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/156720511794604543","volume":"8","author":"C Li","year":"2011","unstructured":"Li C et al. Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer\u2019s disease. Current Alzheimer Research. 2011;8(1):67\u201380.","journal-title":"Current Alzheimer Research"},{"issue":"5","key":"336_CR49","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","volume":"23","author":"Y Li","year":"2003","unstructured":"Li Y et al. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci. 2003;23(5):1605\u201311.","journal-title":"J Neurosci"},{"issue":"1","key":"336_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.035048","volume":"304","author":"B Liu","year":"2003","unstructured":"Liu B, Hong J-S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2003;304(1):1\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"336_CR51","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.neuron.2013.06.046","volume":"79","author":"KM Lucin","year":"2013","unstructured":"Lucin KM et al. Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer\u2019s disease. Neuron. 2013;79(5):873\u201386.","journal-title":"Neuron"},{"issue":"1","key":"336_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12974-014-0161-z","volume":"11","author":"P Majerova","year":"2014","unstructured":"Majerova P et al. Microglia display modest phagocytic capacity for extracellular tau oligomers. J Neuroinflammation. 2014;11(1):161.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"336_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0047-6374(88)90041-3","volume":"43","author":"DM Mann","year":"1988","unstructured":"Mann DM. The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev. 1988;43(2):99\u2013136.","journal-title":"Mech Ageing Dev"},{"issue":"9","key":"336_CR54","doi-asserted-by":"publisher","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","volume":"113","author":"SE Marsh","year":"2016","unstructured":"Marsh SE et al. The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function. Proc Natl Acad Sci. 2016;113(9):E1316\u201325.","journal-title":"Proc Natl Acad Sci"},{"issue":"6523","key":"336_CR55","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/374647a0","volume":"374","author":"L Meda","year":"1995","unstructured":"Meda L et al. Activation of microglial cells by \u03b2-amyloid protein and interferon-\u03b3. Nature. 1995;374(6523):647\u201350.","journal-title":"Nature"},{"issue":"4","key":"336_CR56","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-131843","volume":"37","author":"I Morales","year":"2013","unstructured":"Morales I et al. Tau oligomers and fibrils induce activation of microglial cells. J Alzheimers Dis. 2013;37(4):849\u201356.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"336_CR57","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/oxfordjournals.jbchem.a002969","volume":"130","author":"K Nakajima","year":"2001","unstructured":"Nakajima K, Kohsaka S. Microglia: activation and their significance in the central nervous system. J Biochem. 2001;130(2):169\u201375.","journal-title":"J Biochem"},{"issue":"8","key":"336_CR58","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1248\/bpb.25.945","volume":"25","author":"Y Nakamura","year":"2002","unstructured":"Nakamura Y. Regulating factors for microglial activation. Biol Pharm Bull. 2002;25(8):945\u201353.","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"336_CR59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/078538902321117698","volume":"34","author":"PT Nelson","year":"2002","unstructured":"Nelson PT, Soma LA, Lavi E. Microglia in diseases of the central nervous system. Ann Med. 2002;34(7):491\u2013500.","journal-title":"Ann Med"},{"issue":"3","key":"336_CR60","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1523\/JNEUROSCI.22-03-00854.2002","volume":"22","author":"H Neumann","year":"2002","unstructured":"Neumann H et al. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci. 2002;22(3):854\u201362.","journal-title":"J Neurosci"},{"issue":"40","key":"336_CR61","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"3","key":"336_CR62","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39(3):409\u201321.","journal-title":"Neuron"},{"issue":"7","key":"336_CR63","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cellsig.2010.01.010","volume":"22","author":"KM Park","year":"2010","unstructured":"Park KM, Bowers WJ. Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. Cell Signal. 2010;22(7):977\u201383.","journal-title":"Cell Signal"},{"issue":"4","key":"336_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol. 2010;6(4):193\u2013201.","journal-title":"Nat Rev Neurol"},{"issue":"14","key":"336_CR65","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1073\/pnas.0901229106","volume":"106","author":"G Pigino","year":"2009","unstructured":"Pigino G et al. Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci. 2009;106(14):5907\u201312.","journal-title":"Proc Natl Acad Sci"},{"key":"336_CR66","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40478-015-0199-x","volume":"3","author":"AM Pooler","year":"2015","unstructured":"Pooler AM et al. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease. Acta Neuropathol Commun. 2015;3:14.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"336_CR67","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.nbd.2005.05.027","volume":"20","author":"EM Rib\u00e9","year":"2005","unstructured":"Rib\u00e9 EM et al. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP\/tau transgenic mice. Neurobiol Dis. 2005;20(3):814\u201322.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"336_CR68","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0197-0186(01)00040-7","volume":"39","author":"J Rogers","year":"2001","unstructured":"Rogers J, Lue L-F. Microglial chemotaxis, activation, and phagocytosis of amyloid \u03b2-peptide as linked phenomena in Alzheimer\u2019s disease. Neurochem Int. 2001;39(5):333\u201340.","journal-title":"Neurochem Int"},{"issue":"2","key":"336_CR69","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/glia.10153","volume":"40","author":"J Rogers","year":"2002","unstructured":"Rogers J et al. Microglia and inflammatory mechanisms in the clearance of amyloid \u03b2 peptide. Glia. 2002;40(2):260\u20139.","journal-title":"Glia"},{"issue":"4","key":"336_CR70","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s004010050713","volume":"94","author":"A Sasaki","year":"1997","unstructured":"Sasaki A et al. Microglial activation in early stages of amyloid \u03b2 protein deposition. Acta Neuropathol. 1997;94(4):316\u201322.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"336_CR71","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1016\/j.neurobiolaging.2013.05.003","volume":"34","author":"A Saul","year":"2013","unstructured":"Saul A et al. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2013;34(11):2564\u201373.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"336_CR72","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2353\/ajpath.2006.060002","volume":"169","author":"K Schindowski","year":"2006","unstructured":"Schindowski K et al. Alzheimer\u2019s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol. 2006;169(2):599\u2013616.","journal-title":"Am J Pathol"},{"issue":"1","key":"336_CR73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.144.1.129","volume":"144","author":"K Selmaj","year":"1990","unstructured":"Selmaj K et al. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol. 1990;144(1):129\u201335.","journal-title":"J Immunol"},{"issue":"6","key":"336_CR74","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1172\/JCI31450","volume":"117","author":"SS Shaftel","year":"2007","unstructured":"Shaftel SS et al. Sustained hippocampal IL-1\u03b2 overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest. 2007;117(6):1595\u2013604.","journal-title":"J Clin Invest"},{"issue":"6","key":"336_CR75","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1096\/fj.13-246702","volume":"28","author":"IC Stancu","year":"2014","unstructured":"Stancu IC et al. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer\u2019s disease. Faseb j. 2014;28(6):2620\u201331.","journal-title":"Faseb j"},{"key":"336_CR76","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","volume":"35","author":"AH Stephan","year":"2012","unstructured":"Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci. 2012;35:369\u201389.","journal-title":"Annu Rev Neurosci"},{"issue":"5448","key":"336_CR77","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1126\/science.286.5448.2352","volume":"286","author":"J Tan","year":"1999","unstructured":"Tan J et al. Microglial activation resulting from CD40-CD40L interaction after \u03b2-amyloid stimulation. Science. 1999;286(5448):2352\u20135.","journal-title":"Science"},{"issue":"8","key":"336_CR78","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1074\/jbc.M509145200","volume":"281","author":"K Tanemura","year":"2006","unstructured":"Tanemura K et al. Formation of tau inclusions in knock-in mice with familial Alzheimer disease (FAD) mutation of presenilin 1 (PS1). J Biol Chem. 2006;281(8):5037\u201341.","journal-title":"J Biol Chem"},{"issue":"4791","key":"336_CR79","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.2949367","volume":"235","author":"RE Tanzi","year":"1987","unstructured":"Tanzi RE et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 1987;235(4791):880\u20134.","journal-title":"Science"},{"issue":"5","key":"336_CR80","doi-asserted-by":"publisher","first-page":"e97096","DOI":"10.1371\/journal.pone.0097096","volume":"9","author":"SE Taylor","year":"2014","unstructured":"Taylor SE et al. Rod microglia: a morphological definition. PLoS One. 2014;9(5):e97096.","journal-title":"PLoS One"},{"issue":"1","key":"336_CR81","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-9-20","volume":"9","author":"JD Ulrich","year":"2014","unstructured":"Ulrich JD et al. Altered microglial response to Abeta plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener. 2014;9(1):20.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"336_CR82","first-page":"125","volume":"40","author":"T Wierzba-Bobrowicz","year":"2001","unstructured":"Wierzba-Bobrowicz T et al. Morphological analysis of active microglia--rod and ramified microglia in human brains affected by some neurological diseases (SSPE, Alzheimer\u2019s disease and Wilson\u2019s disease). Folia Neuropathol. 2001;40(3):125\u201331.","journal-title":"Folia Neuropathol"},{"issue":"3","key":"336_CR83","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1471-4159.2004.02737.x","volume":"91","author":"O Wirths","year":"2004","unstructured":"Wirths O, Multhaup G, Bayer TA. A modified \u03b2\u2010amyloid hypothesis: intraneuronal accumulation of the \u03b2\u2010amyloid peptide\u2013the first step of a fatal cascade. J Neurochem. 2004;91(3):513\u201320.","journal-title":"J Neurochem"},{"issue":"3","key":"336_CR84","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53(3):337\u201351.","journal-title":"Neuron"},{"issue":"8","key":"336_CR85","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.tins.2010.05.004","volume":"33","author":"KR Zahs","year":"2010","unstructured":"Zahs KR, Ashe KH. Too much good news\u2019\u2013are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer\u2019s disease? Trends Neurosci. 2010;33(8):381\u20139.","journal-title":"Trends Neurosci"},{"issue":"3","key":"336_CR86","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell. 2013;153(3):707\u201320.","journal-title":"Cell"},{"issue":"1","key":"336_CR87","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1742-2094-9-247","volume":"9","author":"JM Ziebell","year":"2012","unstructured":"Ziebell JM et al. Rod microglia: elongation, alignment, and coupling to form trains across the somatosensory cortex after experimental diffuse brain injury. J Neuroinflammation. 2012;9(1):247.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"336_CR88","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2009.01.013","volume":"209","author":"N Zilka","year":"2009","unstructured":"Zilka N et al. Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy. J Neuroimmunol. 2009;209(1):16\u201325.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"336_CR89","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V","volume":"29","author":"V Zujovic","year":"2000","unstructured":"Zujovic V et al. Fractalkine modulates TNF\u2010\u03b1 secretion and neurotoxicity induced by microglial activation. Glia. 2000;29(4):305\u201315.","journal-title":"Glia"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-016-0336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-016-0336-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-016-0336-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-016-0336-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:33:52Z","timestamp":1692405232000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-016-0336-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,23]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1186\/s40478-016-0336-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,23]]},"assertion":[{"value":"26 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"63"}}